Immunotherapy Suppresses both Th1 and Th2 Responses by Allergen Stimulation, but Suppression of the Th2 Response is a More Important Mechanism Related to the Clinical Efficacy of Immunotherapy for Perennial Allergic Rhinitis

This publication has 29 references indexed in Scilit:

• Ten‐Year Follow‐Up Study of Allergen‐Specific Immunoglobulin E and Immunoglobulin G4, Soluble Interleukin‐2 Receptor, Interleukin‐4, Soluble Intercellular Adhesion Molecule‐1 and Soluble Vascular Cell Adhesion Molecule‐1 in Serum of Patients on Immunotherapy for Perennial Allergic Rhinitis
  Scandinavian Journal of Immunology, 1998
• The importance of Th2‐like cells in the pathogenesis of airway allergic inflammation
  Clinical and Experimental Allergy, 1993
• Predominant T_H2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
  New England Journal of Medicine, 1992
• Do human TH1 and TH2 CD4+ clones exist?
  Research in Immunology, 1991
• Role Of Lymphocyte Adhesion Receptors In Transient Interactions And Cell Locomotion
  Annual Review of Immunology, 1991
• A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses
  Journal of Allergy and Clinical Immunology, 1990
• A double‐blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac®) in patients with perennial rhinitis
  Allergy, 1989
• Basal serum interferon‐gamma production in hay fever patients
  Clinical and Experimental Allergy, 1988
• Two types of mouse helper T-cell clone: Implications for immune regulation
  Immunology Today, 1987
• Regulation of the Human IgE Antibody Response
  International Reviews of Immunology, 1987